CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study

Overview of attention for article published in Annals of Hematology, February 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 2 news outlets
policy: 1 policy source

twitter: 4 X users

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 61 Mendeley

Summary News Policy documents X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,415 followers.

RT @DrPaulyDeSantis: CD19 CAR-T therapy vs chemo in re-induction treatment of r/r ALL $GILD $CELG $NVS https://t.co/YAcrlhQoZp

05 Apr 2018

Reply Repost Favourite

RT @DrPaulyDeSantis: CD19 CAR-T therapy vs chemo in re-induction treatment of r/r ALL $GILD $CELG $NVS https://t.co/YAcrlhQoZp

04 Apr 2018

Reply Repost Favourite

RT @DrPaulyDeSantis: CD19 CAR-T therapy vs chemo in re-induction treatment of r/r ALL $GILD $CELG $NVS https://t.co/YAcrlhQoZp

04 Apr 2018

Reply Repost Favourite

CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study https://t.co/DSbv9NVwI9

10 Feb 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.